RXRX · Recursion Pharmaceuticals, Inc.
$3.50
+0.16 (+4.79%)
At close · Aug 21
Market Cap
$1.87B
Shares
535.34M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-04-30 | 2026-04-28 | |
| DEF 14A | 2026-04-30 | — | |
| 8-K | 2026-03-25 | — | |
| 8-K | 2026-02-25 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-11-26 | — | |
| 8-K | 2025-11-05 | 2025-11-04 | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-29 | — | |
| 8-K/A | 2025-08-29 | 2025-07-08 | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-07-08 | — | |
| 8-K | 2025-06-18 | — | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-05-09 | — | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | — | |
| 8-K | 2025-03-18 | 2025-03-15 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-17 | — | |
| 8-K | 2024-12-03 | 2024-12-02 | |
| 8-K/A | 2024-11-27 | 2024-11-19 | |
| 8-K/A | 2024-11-26 | 2024-08-08 | |
| 8-K | 2024-11-20 | 2024-11-19 | |
| 8-K | 2024-11-13 | 2024-11-12 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-11-06 | 2024-11-05 | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-10-02 | — | |
| 8-K | 2024-09-03 | — | |
| 8-K | 2024-08-28 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | 2024-08-06 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-27 | 2024-06-26 | |
| 8-K | 2024-06-24 | — | |
| 8-K | 2024-06-07 | 2024-06-03 |
Showing 1–50 of 115 filings
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
305 filings
296 filers
Visit website
Investor relations